SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-21-004911
Filing Date
2021-04-27
Accepted
2021-04-27 16:06:35
Documents
5
Period of Report
2021-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20210608xdef14a.htm DEF 14A 755047
2 GRAPHIC tmb-20210608xdef14a014.jpg GRAPHIC 71268
3 GRAPHIC tmb-20210608xdef14a016.jpg GRAPHIC 96460
4 GRAPHIC tmb-20210608xdef14a013.jpg GRAPHIC 83637
5 GRAPHIC tmb-20210608xdef14a015.jpg GRAPHIC 105977
  Complete submission text file 0001558370-21-004911.txt   1248592
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39712 | Film No.: 21858947
SIC: 2834 Pharmaceutical Preparations